• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖衍生物与胰岛素之间的自组装聚电解质纳米复合物

Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin.

作者信息

Mao Shirui, Bakowsky Udo, Jintapattanakit Anchalee, Kissel Thomas

机构信息

Department of Pharmaceutics and Biopharmacy, Philipps-University of Marburg, Ketzerbach 63, D-35032 Marburg, Germany.

出版信息

J Pharm Sci. 2006 May;95(5):1035-48. doi: 10.1002/jps.20520.

DOI:10.1002/jps.20520
PMID:16565978
Abstract

Polyelectrolyte complexes (PEC) formed from chitosan derivatives and insulin was prepared and parameters influencing complex formation were characterized. Turbidimetric titration, in combination with dynamic light scattering (DLS) and laser doppler anemometry (LDA), were used to study the complexation process. The morphology of the PECs was determined using atomic force microscopy (AFM). PEC formation was predominantly pH-dependent. Complexation with insulin occurred only above critical pH value (pHc) of 6.0 for all the chitosan derivatives investigated. Soluble PECs in the size range of 200-500 nm with spherical or subspherical morphology and smooth surface structure were obtained at optimized polymer/insulin charge ratios. Optimal conditions were obtained when the pH of PECs was in the range of 6.5-8.0, depending on polymer structure. The stability of PECs was influenced by polymer chain length. Only when the MW of the polymers was > or =25-kDa PEC precipitation could be avoided. An increase in the ionic strength of the medium accelerated complex dissociation. Chitosan methylation and PEGylation significantly improved the stability of insulin in the PECs. Moreover, the PEC could protect insulin from degradation even at 50 degrees C for at least 6 h. All complexes could be lyophilized without influencing the particle size, complex concentration, and stability of insulin. On the basis of our results, we suggest that interactions involved in PEC formation were predominantly electrostatic in nature, involving the positively charged amino groups of chitosan and the negatively charged insulin above its isoelectric point. Intranasal absorption of the polyelectrolyte nanocomplexes will be studied in vivo.

摘要

制备了由壳聚糖衍生物和胰岛素形成的聚电解质复合物(PEC),并对影响复合物形成的参数进行了表征。采用比浊滴定法,结合动态光散射(DLS)和激光多普勒测速仪(LDA)研究了复合过程。使用原子力显微镜(AFM)测定了PEC的形态。PEC的形成主要取决于pH值。对于所有研究的壳聚糖衍生物,与胰岛素的复合仅在临界pH值(pHc)6.0以上发生。在优化的聚合物/胰岛素电荷比下,获得了尺寸范围为200-500 nm、具有球形或亚球形形态且表面结构光滑的可溶性PEC。根据聚合物结构,当PEC的pH值在6.5-8.0范围内时可获得最佳条件。PEC的稳定性受聚合物链长度的影响。只有当聚合物的分子量≥25 kDa时,才能避免PEC沉淀。介质离子强度的增加加速了复合物的解离。壳聚糖甲基化和聚乙二醇化显著提高了胰岛素在PEC中的稳定性。此外,即使在50℃下至少6小时,PEC也能保护胰岛素不被降解。所有复合物都可以冻干,而不影响颗粒大小、复合物浓度和胰岛素的稳定性。根据我们的结果,我们认为PEC形成过程中涉及的相互作用主要是静电性质的,涉及壳聚糖带正电荷的氨基和高于其等电点带负电荷的胰岛素。将在体内研究聚电解质纳米复合物的鼻内吸收。

相似文献

1
Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin.壳聚糖衍生物与胰岛素之间的自组装聚电解质纳米复合物
J Pharm Sci. 2006 May;95(5):1035-48. doi: 10.1002/jps.20520.
2
Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin.壳聚糖衍生物与依诺肝素之间的自组装聚电解质纳米复合物
Eur J Pharm Biopharm. 2008 Jun;69(2):417-25. doi: 10.1016/j.ejpb.2008.01.016. Epub 2008 Jan 26.
3
Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles.使用壳聚糖衍生物经口递送胰岛素:聚电解质纳米复合物与纳米颗粒的比较研究
Int J Pharm. 2007 Sep 5;342(1-2):240-9. doi: 10.1016/j.ijpharm.2007.05.015. Epub 2007 May 17.
4
Self-assembled Polyelectrolyte Nanocomplexes of Alginate, Chitosan and Ovalbumin.海藻酸钠、壳聚糖和卵清蛋白的自组装聚电解质纳米复合物
Acta Chim Slov. 2010 Jun;57(2):431-41.
5
Bioadhesion and oral absorption of enoxaparin nanocomplexes.依诺肝素纳米复合物的生物黏附性和口服吸收。
Int J Pharm. 2010 Feb 15;386(1-2):275-81. doi: 10.1016/j.ijpharm.2009.11.025. Epub 2009 Dec 1.
6
Formation and properties of positively charged colloids based on polyelectrolyte complexes of biopolymers.基于生物聚合物聚电解质复合物的带正电胶体的形成与性质
Langmuir. 2004 Aug 31;20(18):7766-78. doi: 10.1021/la049460m.
7
Polyelectrolyte complex nanoparticles of amino poly(glycerol methacrylate)s and insulin.氨基酸聚(甘油甲基丙烯酸酯)与胰岛素的聚电解质复合纳米粒。
Int J Pharm. 2012 Feb 28;423(2):195-201. doi: 10.1016/j.ijpharm.2011.12.017. Epub 2011 Dec 17.
8
Influence of chitosan structure on the formation and stability of DNA-chitosan polyelectrolyte complexes.壳聚糖结构对DNA-壳聚糖聚电解质复合物形成及稳定性的影响。
Biomacromolecules. 2005 Nov-Dec;6(6):3357-66. doi: 10.1021/bm0503726.
9
Stabilization of chitosan/hyaluronan colloidal polyelectrolyte complexes in physiological conditions.壳聚糖/透明质酸胶体聚电解质复合物在生理条件下的稳定化。
Carbohydr Polym. 2015 Mar 30;119:149-58. doi: 10.1016/j.carbpol.2014.11.042. Epub 2014 Nov 26.
10
Uptake and transport of PEG-graft-trimethyl-chitosan copolymer-insulin nanocomplexes by epithelial cells.上皮细胞对聚乙二醇接枝三甲基壳聚糖共聚物-胰岛素纳米复合物的摄取与转运
Pharm Res. 2005 Dec;22(12):2058-68. doi: 10.1007/s11095-005-8175-y. Epub 2005 Sep 26.

引用本文的文献

1
Effect of Degree of Substitution and Polymer Ratio on the Structure of Chitosan: Carboxymethyl Starch (Bio)Polyelectrolyte Complexes.取代度和聚合物比例对壳聚糖:羧甲基淀粉(生物)聚电解质复合物结构的影响。
Polymers (Basel). 2024 Dec 19;16(24):3539. doi: 10.3390/polym16243539.
2
Effect of C7-3-Peptide-Loaded Chitosan Nanoparticles Against Multi-Drug-Resistant .载 C7-3 肽壳聚糖纳米粒对多重耐药菌的作用。
Int J Nanomedicine. 2024 Jan 19;19:609-631. doi: 10.2147/IJN.S445737. eCollection 2024.
3
Comparison of virus-capsid mimicking biologic-shell based versus polymeric-shell nanoparticles for enhanced oral insulin delivery.
基于病毒衣壳模拟生物壳与聚合物壳纳米颗粒用于增强口服胰岛素递送的比较。
Asian J Pharm Sci. 2023 Sep;18(5):100848. doi: 10.1016/j.ajps.2023.100848. Epub 2023 Sep 24.
4
Mucoadhesive Nanoparticles Enhance the Therapeutic Effect of Dexamethasone on Experimental Ulcerative Colitis by the Local Administration as an Enema.黏膜黏附纳米粒通过灌肠局部给药增强地塞米松对实验性溃疡性结肠炎的治疗作用。
Drug Des Devel Ther. 2023 Jan 24;17:191-207. doi: 10.2147/DDDT.S390274. eCollection 2023.
5
Formulation development, and evaluation of chitosan engineered nanoparticles for ocular delivery of insulin.用于胰岛素眼部递送的壳聚糖工程纳米颗粒的制剂开发与评价
RSC Adv. 2020 Dec 8;10(71):43629-43639. doi: 10.1039/d0ra07640f. eCollection 2020 Nov 27.
6
Nanoparticle Delivery Systems in the Treatment of Diabetes Complications.纳米颗粒递药系统在糖尿病并发症治疗中的应用
Molecules. 2019 Nov 20;24(23):4209. doi: 10.3390/molecules24234209.
7
Needle-Free Immunization with Chitosan-Based Systems.无针免疫接种用壳聚糖体系。
Int J Mol Sci. 2018 Nov 19;19(11):3639. doi: 10.3390/ijms19113639.
8
Nanoparticles Prepared From N,N-Dimethyl-N-Octyl Chitosan as the Novel Approach for Oral Delivery of Insulin: Preparation, Statistical Optimization and Characterization.以N,N-二甲基-N-辛基壳聚糖制备的纳米颗粒作为胰岛素口服递送的新方法:制备、统计学优化及表征
Iran J Pharm Res. 2018 Spring;17(2):442-459.
9
Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax.三甲基壳聚糖纳米颗粒包裹保护性抗原可保护小鼠免受炭疽病侵害。
Front Immunol. 2018 Mar 20;9:562. doi: 10.3389/fimmu.2018.00562. eCollection 2018.
10
Composite carbohydrate interpenetrating polyelectrolyte nano-complexes (IPNC) as a controlled oral delivery system of citalopram HCl for pediatric use: in-vitro/in-vivo evaluation and histopathological examination.复合碳水化合物互穿聚电解质纳米复合物(IPNC)作为一种用于儿科的西酞普兰 HCl 的控制口服递送系统:体外/体内评价和组织病理学检查。
Drug Deliv Transl Res. 2018 Jun;8(3):657-669. doi: 10.1007/s13346-018-0506-8.